Clinical trial · Observational
Social Inequalities in the Participation and Activity in Children and Adolescents With Hodgkin-lymphoma
Social Inequalities in the Participation and Activity in Children and Adolescents With Hodgkin-lymphoma. A Prospective Multicenter Cohort Study of Social and Personal Influencing Factors
NCT02808520CI-TRIAL-00022650unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Purpose of this study is to determine the influence of social factors on participation and activity among children and adolescents aged 10-18 years with hodgkin-lymphoma. Furthermore personal and treatment-related factors and their impact on participation will be explored.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Classical Hodgkin Lymphoma | Classic Hodgkin Lymphoma | CURATED_BROADER | 0.80 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Hodgkin-lymphoma
- description
- Children and adolescents aged 10-18 years
Primary outcomes (2)
- measure
- Social participation
- timeFrame
- one month after diagnosis until two years
- description
- The Child and Adolescent Scale of Participation, CASP
- measure
- Quality of life
- timeFrame
- one month after diagnosis until two years
- description
- Questionnaire to assess Health Related Quality of Life in chronically ill Children and Adolescents, KINDL
Secondary outcomes (10)
- measure
- Understanding of illness
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 10 Years
- Maximum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * histologically confirmed primary diagnosis of classical Hodgkin's Lymphoma * 10-18 years * written informed consent of the patient and/or the patient's parents or guardian according to national laws Exclusion Criteria: * other (simultaneous) malignancies
References
Publications (0)
Data not yet available
No reference posted for this study.